Literature DB >> 11846927

Age and radiation response in glioblastoma multiforme.

F G Barker1, S M Chang, D A Larson, P K Sneed, W M Wara, C B Wilson, M D Prados.   

Abstract

OBJECTIVE: Advanced age is a strong predictor of shorter survival in patients with glioblastoma multiforme (GM), especially for those who receive multimodality treatment. Radiographically assessed tumor response to external beam radiation therapy is an important prognostic factor in GM. We hypothesized that older GM patients might have more radioresistant tumors.
METHODS: We studied radiographically assessed response to external beam radiation treatment (five-level scale) in relation to age and other prognostic factors in a cohort of 301 GM patients treated on two prospective clinical protocols. A total of 223 patients (74%) were assessable for radiographically assessed radiation response. A proportional odds ordinal regression model was used for univariate and multivariate analysis.
RESULTS: Younger age (P = 0.006), higher Karnofsky Performance Scale score before radiotherapy (P = 0.027), and more extensive surgical resection (P = 0.028) predicted better radiation response in univariate analyses. Results were similar when clinical criteria were used to classify an additional 61 patients without radiographically assessed radiation response (stable versus progressive disease). In multivariate analyses, age and extent of resection were significant independent predictors of radiation response (P < 0.05); Karnofsky Performance Scale score was of borderline significance (P = 0.07).
CONCLUSION: Older GM patients are less likely to have good responses to postoperative external beam radiation therapy. Karnofsky Performance Scale score before radiation treatment and extent of surgical resection are additional predictors of radiographically assessed radiation response in GM.

Entities:  

Mesh:

Year:  2001        PMID: 11846927     DOI: 10.1097/00006123-200112000-00002

Source DB:  PubMed          Journal:  Neurosurgery        ISSN: 0148-396X            Impact factor:   4.654


  30 in total

1.  Increased re-entry into cell cycle mitigates age-related neurogenic decline in the murine subventricular zone.

Authors:  Elizabeth A Stoll; Behnum A Habibi; Andrei M Mikheev; Jurate Lasiene; Susan C Massey; Kristin R Swanson; Robert C Rostomily; Philip J Horner
Journal:  Stem Cells       Date:  2011-12       Impact factor: 6.277

2.  Reply to: age as a predictive factor in glioblastomas: population-based study.

Authors:  Andrei M Mikheev; Philip J Horner; Rohan Ramakrishna; John-Patrick Maxwell; Elizabeth A Stoll; Robert C Rostomily
Journal:  Neuroepidemiology       Date:  2010-01-13       Impact factor: 3.282

Review 3.  Brain tumor epidemiology: consensus from the Brain Tumor Epidemiology Consortium.

Authors:  Melissa L Bondy; Michael E Scheurer; Beatrice Malmer; Jill S Barnholtz-Sloan; Faith G Davis; Dora Il'yasova; Carol Kruchko; Bridget J McCarthy; Preetha Rajaraman; Judith A Schwartzbaum; Siegal Sadetzki; Brigitte Schlehofer; Tarik Tihan; Joseph L Wiemels; Margaret Wrensch; Patricia A Buffler
Journal:  Cancer       Date:  2008-10-01       Impact factor: 6.860

4.  Treatment of glioblastoma in elderly patients.

Authors:  Florian Stockhammer
Journal:  CNS Oncol       Date:  2014-03

5.  Xenograft-based, platform-independent gene signatures to predict response to alkylating chemotherapy, radiation, and combination therapy for glioblastoma.

Authors:  Shuang G Zhao; Menggang Yu; Daniel E Spratt; S Laura Chang; Felix Y Feng; Michelle M Kim; Corey W Speers; Brett L Carlson; Ann C Mladek; Theodore S Lawrence; Jann N Sarkaria; Daniel R Wahl
Journal:  Neuro Oncol       Date:  2019-09-06       Impact factor: 12.300

6.  A phase II study of radiotherapy after hyperbaric oxygenation combined with interferon-beta and nimustine hydrochloride to treat supratentorial malignant gliomas.

Authors:  Takaaki Beppu; Katsura Kamada; Ryuji Nakamura; Hiroshi Oikawa; Masaru Takeda; Takeshi Fukuda; Hiroshi Arai; Kuniaki Ogasawara; Akira Ogawa
Journal:  J Neurooncol       Date:  2003-01       Impact factor: 4.130

7.  Glioblastoma multiforme in the elderly: a therapeutic challenge.

Authors:  A Mangiola; G Maira; P De Bonis; M Porso; B Pettorini; G Sabatino; C Anile
Journal:  J Neurooncol       Date:  2006-01       Impact factor: 4.130

8.  Recovery of white matter tracts in regions of peritumoral FLAIR hyperintensity with use of restriction spectrum imaging.

Authors:  C R McDonald; N S White; N Farid; G Lai; J M Kuperman; H Bartsch; D J Hagler; S Kesari; B S Carter; C C Chen; A M Dale
Journal:  AJNR Am J Neuroradiol       Date:  2012-12-28       Impact factor: 3.825

Review 9.  The impact of age on oncogenic potential: tumor-initiating cells and the brain microenvironment.

Authors:  Elizabeth A Stoll; Philip J Horner; Robert C Rostomily
Journal:  Aging Cell       Date:  2013-06-28       Impact factor: 9.304

10.  Addition of MR imaging features and genetic biomarkers strengthens glioblastoma survival prediction in TCGA patients.

Authors:  Manal Nicolasjilwan; Ying Hu; Chunhua Yan; Daoud Meerzaman; Chad A Holder; David Gutman; Rajan Jain; Rivka Colen; Daniel L Rubin; Pascal O Zinn; Scott N Hwang; Prashant Raghavan; Dima A Hammoud; Lisa M Scarpace; Tom Mikkelsen; James Chen; Olivier Gevaert; Kenneth Buetow; John Freymann; Justin Kirby; Adam E Flanders; Max Wintermark
Journal:  J Neuroradiol       Date:  2014-07-02       Impact factor: 3.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.